The 13th Annual New Therapeutics in Hematology and Oncology: The Road to Personalized Medicine is dedicated to drug and treatment updates with a focus on gynecological malignancies, precision medicine, prostate, hematologic malignancies, GI malignancies and bladder cancer.
The 13th Annual New Therapeutics in Hematology and Oncology: The Road to Personalized Medicine covers topics such as:
- Personalized treatment plans for patients based upon an evaluation of efficacy and safety of current and newly approved agents and therapeutic options
- New, emerging and novel therapeutic agents, advances in care, and clinical trial data and apply relevant findings into the management of cancer patients
- AJCC or other appropriate staging in clinical practice , including appropriate prognostic indicators and evidence-based national guidelines for treatment planning
- Appropriate strategies into clinical practice to optimize the management of patients with gynecologic malignancies to improve patient outcomes
- The principles, techniques, and applications of precision medicine, including genomic and molecular profiling, biomarker discovery, targeted therapies, and personalized care, in order to appreciate the potential benefits, limitations, and ethical considerations of this emerging approach to healthcare
The 13th Annual New Therapeutics in Hematology and Oncology: The Road to Personalized Medicine will be held in Los Angeles, United States on 15-16 Nov 2024.
